Next-Generation Bruton Tyrosine Kinase Inhibitors

This review describes the mechanism of second-generation Bruton tyrosine kinase inhibitors (BTKi), highlights the differences between the second- and first-generation BTKi, and introduces the third generation of BTKi that address resistance developed with covalent inhibitors.

Journal of Clinical Oncology